Tag: mhra
Patient Information Leaflet Problems: Your Right to Compensation
Failure in the patient information leaflet problems can potentially endanger countless patients who depend on medications for treatment.
In May 2025, the Medicines and Healthcare Products Regulatory Agency (MHRA) issued a critical Class 4 Medicines Notification concerning multiple topical steroid products manufactured by Chemidex Pharma Ltd. The core issue lies in the patient information leaflets (PILs) included with these medications, which reportedly omitted vital safety information about potential side effects, specifically visual disturbances such as blurred vision or other ocular complications.
The absence of accurate information in patient information leaflets can have far-reaching consequences, as patients rely on these documents to understand the risks associated with their medications.
Multiple Injuries Legal Action: Claiming Compensation with The Group Action Lawyers
If you have experienced harm alongside others due to negligence or misconduct, you may be eligible to join a multiple injuries legal action.
When multiple individuals suffer injuries from the same event or source, pursuing compensation through a group action can be an effective way to achieve justice. The Group Action Lawyers specialise in managing complex group claims, ensuring victims receive the compensation they deserve.
Press-In-Bottle-Adaptor Issue – MHRA In The News
A recent MHRA alert has brought a Press-In-Bottle-Adaptor issue into sharp focus, raising concerns about the safety and effectiveness of certain medicines.
Specifically, the issue reportedly affects Mycophenolate Mofetil 1g/5ml Oral Suspension, a medication crucial for patients undergoing organ transplantation or managing autoimmune conditions.
At The Group Action Lawyers, we are experts in cases involving defective products and medicines. We are here to support victims of defects, helping them claim compensation for any harm caused.
Vaginal Mesh Degrades: Claiming Compensation in a Group Action
Whilst implants were initially introduced as a solution for pelvic organ prolapse and stress urinary incontinence, their widespread use has led to reports of severe complications when the vaginal mesh degrades.
The controversy surrounding vaginal mesh implants has brought to light the devastating potential impact these devices have had on the lives of countless women. These complications can be life-altering, and many patients are now seeking justice through legal action.
At The Group Action Lawyers, we are committed to helping victims claim the compensation they deserve.
CPT Hip System Femoral Stem MHRA Matter
If you have experienced complications following surgery involving the CPT Hip System Femoral Stem, the matter was recently highlighted in a recent MHRA alert.
Patients with this medical device potentially face some risks, and The Group Action Lawyers are assessing the situation.
Philips Respironics Ventilators: MHRA Matters In The News
The recent Field Safety Notice involving Philips Respironics ventilators has raised concerns, perhaps particularly among patients who may rely on these devices for critical respiratory support.
The Medicines and Healthcare products Regulatory Agency (MHRA) issued an alert concerning issues in the use of Philips Respironics BiPAP A-Series ventilators, which could lead to therapy interruptions.
Legency Remedies Eye Wash Recall
The safety of medical products is paramount, especially when they are meant to address critical health needs. We look at the Legency Remedies eye wash recall.
When products like eye wash solutions are recalled due to safety concerns, individuals who have used them may face unforeseen health risks. If you have suffered as a result of such issues, you may be entitled to compensation.
At The Group Action Lawyers, we specialise in helping individuals navigate the complexities of group action claims arising from product recalls.
MHRA Matters: Safeguarding Against Counterfeit LifeVac Anti-Choking Devices
MHRA safety notification issues over LifeVac anti-choking devices: The safety and well-being of individuals, especially in emergencies, is paramount.
When it comes to life-threatening situations like choking incidents, having reliable devices such as the LifeVac anti-choking device can make all the difference. However, recent alerts from the Medicines and Healthcare products Regulatory Agency (MHRA) have raised concerns about counterfeit and unbranded copies of LifeVac devices. These counterfeit products may fail to work correctly or worsen choking incidents if used, posing significant risks to users.
At The Group Action Lawyers, we are committed to helping victims of defective products seek compensation through group actions, ensuring they receive the justice and support they deserve. We also cover general stories such as this one published by the MHRA that are relevant to our industry.
Empowering Rights: MHRA International Recognition Procedure
Unveiling the MHRA International Recognition Procedure (IRP): The Medicines and Healthcare products Regulatory Agency (MHRA) has launched its groundbreaking new venture.
The MHRA International Recognition Procedure (IRP) marks a significant milestone in regulatory affairs in our view. This new procedure, effective from January 1, 2024, is intended to streamline the recognition of medicines and medical devices, fostering international collaboration and efficiency.
In this article, we take a look at the MHRA’s IRP and how this could tie in with individuals seeking compensation, and how The Group Action Lawyers can guide you through the claims process.
Claiming Compensation: Patient Information Leaflet Errors and Group Actions
Unveiling the Impact of Patient Information Leaflet Errors: In the world of the importance of healthcare, leaflets play a crucial role in ensuring individuals are well-informed about their medications.
Unfortunately, errors in these leaflets can lead to serious consequences, affecting the health and well-being of patients. In this article, we delve into the significance of patient information leaflet errors and how individuals could be eligible to seek compensation through group actions. We will also take a look at a recent MHRA recall involving Tramadol Hydrochloride 50mg capsules by Strandhaven Ltd t/a Somex Pharma.